Suzhou Suncadia Biopharmaceuticals
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (78)
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma
Started: 10/28/2024
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
Started: 10/30/2025
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Started: 3/30/2026
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
Started: 2/12/2026
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Started: 8/18/2025
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Started: 1/21/2026
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
Started: 8/20/2025
Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
Started: 10/22/2025
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Started: 4/24/2025
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
Started: 4/29/2025
A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
Started: 11/4/2024
SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
Started: 5/10/2024
A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC
Started: 11/29/2024
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
Started: 6/1/2026
Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan
Started: 3/1/2024
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
Started: 2/26/2022
A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
Started: 12/6/2021
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
Started: 2/1/2025
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
Started: 1/17/2022
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
Started: 4/29/2026
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
Started: 3/23/2026
A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
Started: 3/25/2026
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Started: 7/22/2025
A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Started: 7/8/2025
Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
Started: 3/14/2023
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Started: 8/28/2025
A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
Started: 6/24/2025
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Started: 4/25/2025
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC
Started: 3/7/2025
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Started: 2/26/2025
SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
Started: 7/5/2022
Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
Started: 3/11/2024
Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer
Started: 1/26/2022
A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC
Started: 6/22/2021
SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Started: 7/1/2024
Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients
Started: 9/13/2022
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
Started: 10/22/2021
Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients
Started: 9/20/2024
Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
Started: 6/9/2021
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer
Started: 2/15/2024
A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors
Started: 1/7/2026
A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma
Started: 4/14/2026
A Clinical Study of SHR-9539 in Patients With Multiple Myeloma
Started: 8/7/2024
A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors
Started: 2/27/2026
A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
Started: 3/16/2026
Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
Started: 1/6/2026
A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors
Started: 8/28/2025
A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor
Started: 12/23/2025
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Started: 1/21/2025
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Started: 2/18/2025
A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors
Started: 11/13/2024
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
Started: 3/18/2025
A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors
Started: 7/22/2025
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer
Started: 7/11/2025
Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Started: 6/16/2025
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Started: 4/25/2025
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
Started: 4/2/2025
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
Started: 2/18/2025
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors
Started: 12/25/2023
A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
Started: 12/10/2024
A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors
Started: 4/18/2023
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
Started: 8/2/2022
Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer
Started: 8/15/2022
Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC
Started: 10/10/2024
PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases
Started: 5/20/2024
A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
Started: 11/1/2025
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
Started: 5/24/2024
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
Started: 7/21/2022
Study of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors
Started: 12/30/2022
Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors
Started: 6/1/2021
A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices
Started: 12/24/2023
Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors
Started: 12/1/2023
Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer
Started: 10/1/2022
A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma
Started: 6/1/2026
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
Started: 6/1/2026
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Started: 2/1/2025